|
Canada-NS-HALIFAX Azienda Directories
|
Azienda News:
- One shot to stop HIV: MITs bold vaccine breakthrough
Massachusetts Institute of Technology "One shot to stop HIV: MIT's bold vaccine breakthrough " ScienceDaily ScienceDaily, 20 June 2025 <www sciencedaily com releases 2025 06
- Supercharged vaccine could offer strong protection with just . . .
Researchers generated a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants to the vaccine This strategy could lead to vaccines that only need to be given once, for infectious diseases including HIV or SARS-CoV-2
- Always ‘one atom away’: The long, rocky journey to an HIV . . .
Note: Lenacapavir PrEP was Science’s 2024 Breakthrough of the Year For his contribution to its development, Sundquist was awarded the AAAS Mani L Bhaumik Breakthrough of the Year Award on 8 May, along with Moupali Das,vice president, clinical development, HIV prevention and pediatrics at Gilead; and Yvette Raphael, co-founder and executive director of Advocacy for Prevention of HIV and AIDS
- Scientists Discover Long-Lasting Immune Boost with Two . . .
In a quiet lab where biotechnology and immunology collide, researchers may have taken a major step toward one of medicine’s most elusive goals: a single-shot vaccine for HIV It’s a disease that has defied decades of scientific effort, evolving like a ghost through the immune system, always a step ahead of the body’s defenses
- Two-part vaccine strategy generates a stronger, longer . . .
The approach, described in Science Translational Medicine on June 18, 2025, used a mouse model to test two types of adjuvants: immune-boosting molecules that improve vaccine response One of the adjuvants helped the HIV protein persist longer in the body, and another amplified immune activation
- Groundbreaking single-dose vaccine found effective in . . .
Scientists have developed a vaccine which provides a strong immune response against HIV in mice, an advance that could lead to potent single-dose vaccines for a range of infectious diseases The
- Groundbreaking HIV supercharged vaccine could protect well . . .
Researchers from MIT and the Scripps Research Institute have unveiled a potent vaccine strategy capable of generating a robust immune defense against HIV with just a single dose By fusing two powerful immune-boosting agents known as adjuvants, scientists have paved the way for a potentially game-changing leap in vaccine technology
|
|